Coxsackievirus B3 clinical isolates and murine myocarditis

Virus Research

Volumn 41, Issue 1, 1996, Pages 89-99

  Gauntt, Charles J ^a   Pallansch, Mark A ^b  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

5' Nontranslated region; Cardiovirulence; Coxsackievirus B3; RNA sequence

Indexed keywords

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; COXSACKIE VIRUS B3; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA SEQUENCE; VIRUS MYOCARDITIS;

ANIMALIA; COXSACKIEVIRUS; MURINAE;

EID: 0029870021     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/0168-1702(95)01250-8     Document Type: Article

References (66)

1. Agol, V.I. (1991) The 5′-untranslated region of picornaviral genomes. Adv. Virus Res. 40, 103-180.
2. Almond, J.W. (1987) The attenuation of poliovirus neurovirulence. Ann. Rev. Microbiol. 41, 153-180.
3. Beck, M.A., Kolbeck, P.C., Rohr, L.H. Shi, Q, Morris, V.C and Levander, O.A. (1994) Benign human enterovirus becomes virulent in selenium-deficient mice. J. Med. Virol. 43, 166-1170.
4. Beck, M.A., Shi, Q., Morris, V.C., and Levander, O.A. (1995) Rapid genomic evolution of a non-virulent coxsackievirus B3 in selenium-dificient mice results in selection of identical virulent isolates. Nature Medicine 1, 433-436.
5. Beisel, K.W., and Traystman, M.D. (1988) Viral myocarditis immunogenetic and autoimmune aspects. In: H.-P. Schultheiss (Ed), New Concepts in Viral Heart Disease, pp. 148-159. Springer-Verlag, Berlin.
6. Borman, A.M., Deliat, F.G. and Kean, K.M. (1994) Sequences within the poliovirus internal ribosome entry segment control viral RNA synthesis. EMBO J. 13, 3149-3157.
7. Caggana, M., Chan, P. and Ramsingh, A. (1993) Identification of a single amino acid residue in the capsid protein VP1 of coxsackievirus B4 that determines the virulent phenotype. J. Virol. 67, 4797-4803.
8. Chapman, N.M., Tu, Z., Tracy, S. and Gauntt, C.J. (1994) An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackievirus. Arch. Virol. 135, 115-130.
9. Chatterjee, N.K. (1988) Replication. In: M. Bendinelli and H. Friedman (Eds), Coxsackieviruses - A General Update, pp. 35-50. Plenum Press, New York.
10. Cherry, J.D. (1995) Enteroviruses. In: J.S. Remington and J.D. Klein (Eds), Infectious Diseases of the Fetus and Newborn Infant, 4th ed, pp. 404-446. W.B. Saunders, Philadelphia.
11. Chow, L.H., Gauntt, C.J., and McManus, B.M. (1991) Differential effects of myocarditic variants of coxsackievirus B3 in inbred mice: a pathologic characterization of heart tissue damage. Lab. Invest. 64, 55-64.
12. Christodoulou, C., Colbere-Garapin, F., Macadam, A., Taffs, L.F., Marsden, S., Minor, P. and Horaud, F. (1990) Mapping of mutations associated with neurovirulence in monkeys infected with Sabin 1 poliovirus revertants selected at high temperature. J. Virol. 64, 4922-4929.
13. Crowell, R.L., and Syverton, J.T. (1955) The viral range in vitro of a malignant, human epithelial cell (strain HeLa, Gey). IV. The cytopathogenicity of C viruses. J. Immunol. 74, 169-177.
14. Cunningham, M.W., Antone, S.M., Gulizia, J.M., McManus, B.M., Fischetti, V.A., and Gauntt, C.J. (1992) Cytotoxic and viral neutralizing antibodies crossreact with streptococcal M protein, enteroviruses and human cardiac myosin. Proc. Natl. Acad. Sci. USA 89, 1320-1324.
15. del Angel, R.M., Papavassiliou, A.G., Fernandez-Tomas, C., Silverstein, S.J. and Rancaniello, V.R. (1989) Cell proteins bind to multiple sites within the 5′ untranslated region of poliovirus RNA. Proc. Natl. Acad. Sci. USA 86, 8299-8303.
16. Gauntt, C.J. (1988) The possible role of viral variants in pathogenesis. In: M. Bendinelli and H. Friedman (Eds), Coxsackieviruses - A General Update, pp. 159-179. Plenum Press, New York.
17. Gauntt, C.J., Trousdale, M.D., LaBadie, D.R.L., Paque, R.E. and Nealon, T. (1979) Properties of coxsackievirus B3 variants which are amyocarditic or myocarditic for mice. J. Med. Virol. 3, 207-220.
18. Gauntt, C.J., Gomez, P.T., Duflfey, P.S., Grant, J.A., Trent, D.W., Witherspoon, S.M. and Paque, R.E. (1984) Characterization and myocarditic capabilities of coxsackievirus B3 variants in selected murine strains. J. Virol. 52, 598-605.
19. Gauntt, C.J., Lutton, C.W., Godeny, E.K., Witherspoon, S.M., Arizpe, H.M. and Lanford, R.E. (1987) Murine coxsackievirus B3 myocarditis. Eur. Heart J. 8(Suppl. J), 393-397.
20. Gauntt, C.J., Godeny, E.K. and Lutton, C.W. (1988) Host factors regulating viral clearance. Pathol. Immunopathol. Res. 7, 251-265.
21. Gauntt, C.J., Maull, E.A., Higdon, A.L., Arizpe, H.M., Lutton, C.W., Beck, M.A., Chapman N.M., McManus, B.M., Mullican, J.C. and Tracy, ST. (1992) Specific and nonspecific heart defenses in enteroviral infections. In: H.R. Figulla (Ed), Idiopathic Dilated Cardiomyopathy, pp. 310-321. Springer-Verlag, Berlin.
22. Gauntt, C., Higdon, A., Bowers, D., Maull, E., Wood, J. and Crawley, R. (1993) What lessons can be learned from animal model studies in viral heart diseases? Scand. J. Infect. Dis. 88(Suppl), 49-65.
23. Gauntt, C.J., Arizpe, H.M., Higdon, A.L., Wood, H.J., Bowers, D.F., Rozek, M.M. and Crawley, R. (1995) Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies and myocarditis. J. Immunol. 154, 2983-2995.
24. Gebhard, J.R. and Ehrenfeld, E. (1992) Specific interactions of HeLa cell proteins with proposed translation domains of the poliovirus 5′ noncoding region. J. Virol. 66, 3101-3109.
25. Godeny, E.K. and Gauntt, C.J. (1986) Involvement of natural killer cells in coxsackievirus B3-induced murine myocarditis. J. Immunol. 137, 1695-1702.
26. Godeny, E.K., Arizpe, H.M. and Gauntt, C.J., (1988) Characterization of the antibody response in vaccinated mice protected against coxsackievirus B3-induced myocarditis. Viral Immunol. 1, 305-314.
27. Hellen, C.V.T., Pestova, T.V., Litterst, M. and Wimmer, E. (1994) The cellular peptide p57 (pyrimidine tract-binding protein) binds to multiple sites in the poliovirus 5′ nontranslated region. J. Virol. 68, 941-950.
28. Huber, S.A., Weller, A., Herzum, M., Lodge, P.A., Estrin, M., Simpson, K. and Guthrie, M. (1988) Immunopathologic mechanisms in experimental picornavirus-induced autoimmunity. Pathol. Immunopathol. Res. 7, 279-291.
29. Huber, S.A., Haisch, C. and Lodge, P.A. (1990) Functional diversity in vascular endothelial cells: role in coxsackievirus tropism. J. Virol. 64, 4516-4522.
30. Huber, S.A., Moraska, A. and Cunningham, M.W. (1994) Alterations in major histocompatability complex association of myocarditis induced by coxsackievirus B3 mutants selected with monoclonal antibodies to group A streptococci. Proc. Natl. Acad. Sci. USA 91, 5543-5547.
31. Iizuka, N., Kohara, M., Hagino, K.-Y., Abe, S., Komatsu, T., Tago, K., Arita, M. and Nomoto, A. (1989) Construction of less neurovirulent polioviruses by introducing deletions into the 5′ noncoding sequence of the genome. J. Virol. 63, 5354-5363.
32. Iizuka, N., Yonekawa, H. and Nomoto, A. (1991) Nucleotide sequence important for translation initiation of enterovirus RNA. J. Virol. 65, 4867-4873.
33. Kaplan, M.H. (1988) Coxsackievirus infection in children under three months of age. In: M. Bendinelli and H. Friedman (Eds), Coxsackieviruses - A General Update, pp. 241-249. Plenum Press, New York.
34. Klump, W.M., Bergmann, I., Muller, B.C., Ameis, D. and Kandolf, R. (1990) Complete nucleotide sequence of infectious coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J. Virol. 64, 1573-1583.
35. Kuge, S. and Nomoto, A. (1987) Construction of viable deletion and insertion mutants of the sabin strain of type 1 poliovirus: function of the 5′ noncoding sequence in viral replication. J. Virol. 61, 1478-1487.
36. Le, S.-Y., Chen, J.H., Sonenberg, N. and Maizel, J.V. (1992) Conserved tertiary structure elements in the 5′ untranslated region of human enteroviruses and rhinoviruses. Virology 191, 858-866.
37. Le, S.-Y. and Zucker, M. (1990) Common structures of the 5′-non-coding RNA in enteroviruses and rhinoviruses. Thermo-dynamical stability and statistical significance. J. Mol. Biol. 216, 729-741.
38. Leslie, K., Blay, R., Haisch, C., Lodge, A., Weller, A. and Huber, S. (1989) Clinical and experimental aspects of viral myocarditis. Clin. Microbiol. Rev. 2, 191-203.
39. Linberg, A., Stalhandske, P. and Petterson, U. (1987) Genome of Coxsackievirus B3. Virology 156, 50-63.
40. Lutton, C.W. and Gauntt, C.J. (1986) Coxsackievirus B3 infection alters plasma membrane of neonatal skin fibroblasts. J. Virol. 60, 294-296.
41. McManus, B.M., Gauntt, C.J. and Cassling, R.S. (1987) Immunopathologic basis of myocardial injury. Cardiovascular Clinics 18, 163-184.
42. Meerovitch, K., Nicholson, R. and Sonenberg, N. (1991) In vitro mutational analysis of cis-acting RNA translational elements within the poliovirus type 2 5′ untranslated region. J. Virol. 65, 5895-5901.
43. Pallansch, M.A. (1988) Epidemiology of group B coxsackieviruses. In: M. Bendinelli and H. Friedman (Eds), Coxsackieviruses - A General Update, pp. 399-417. Plenum Press, New York.
44. Pestova, T.V., Hellen, C.U.T. and Wimmer, E. (1991) Translation of poliovirus RNA: role of an essential cis-acting oligopyrimidine element within the 5′ nontranslated region and involvement of a cellular 57-kilodalton protein. J. Virol. 65, 6194-6204.
45. Pilipenko, E.V., Blinov, V.M., Romanova, L.I., Sinyakov, A.N., Maslova, S.V. and Agol, V.I. (1989) Conserved structural domains in the 5′-untranslated region of picornaviral genomes: an analysis of the segment controlling translation and neurovirulence. Virology 168, 201-209.
46. Racaniello, V.R. (1988) Poliovirus neurovirulence. Adv. Virus Res. 34, 217-246.
47. Ren, R.B., Moss, E.G. and Racaniello, V.R. (1991) Identification of two determinants that attenuate vaccine-related type 2 poliovirus. J. Virol. 65, 1377-1380.
48. Reyes, M.P. and Lerner, A.M. (1988) Myocarditis. Clinical and experimental correlates. In: M. Bendinelli and H. Friedman (Eds), Coxsackieviruses - A General Update, pp. 253-270. Plenum Press, New York.
49. Romero, J.R. and Rotbart, H.R. (1995) Sequence analysis of the downstream 5′ nontranslated region of seven echoviruses with different neurovirulence phenotypes. J. Virol. 69, 1370-1375.
50. Rico-Hesse, R., Pallansch, M.A., Nottay, B.K. and Kew, O.M. (1987) Geographic distribution of wild poliovirus type 1 genotypes. Virology 160, 311-322.
51. Rose, N.R., Neu, N., Neumann, D.A. and Herskowitz, A. (1988) Myocarditis: a postinfectious autoimmune disease. In: H.-P. Schultheiss (Ed), New Concepts in Viral Heart Disease, pp. 139-147. Springer-Verlag, Berlin.
52. See, D.M. and Tilles, J.G. (1991) Viral myocarditis. Rev. Infect. Dis. 13, 951-956.
53. Svitkin, Y.V., Meerovich, K., Lee, H.S., Dholakia, J.N., Kenan, D.J., Agol, V.I. and Soneberg, N. (1994) Internal translation initiation on poliovirus RNA: futher characterization of La function in poliovirus translation in vitro. J. Virol. 68, 1544-1550.
54. Tracy, S. and Gauntt, C.J. (1987) Phenotypic and genotypic differences among naturally occurring coxsackievirus B3 variants. Eur. Heart J. 8(Suppl. J), 445-448.
55. Tracy, S., Chapman, N. and Liu, H. (1985a) Molecular cloning and partial characterization of the coxsackievirus B3 genome. Arch. Virol. 85, 157-163.
56. Tracy, S., Liu, H.-L. and Chapman, N.M. (1985) Coxsackievirus B3: primary structure of the 5 non-coding and capsid protein coding regions of the genome. Virus Res. 3, 263-270.
57. Tracy, S., Wiegand, V., McManus, B., Gauntt, C., Pallansch, M., Beck, M. and Chapman, N. (1990) Molecular approaches to enteroviral diagnosis in idiopathic cardiomyopathy and myocarditis. J. Am. Coll. Cardiol. 15, 1688-1694.
58. Tracy, S., Chapman, N.M. and Beck, M.A. (1991) Molecular biology and pathogenesis of coxsackie B viruses. Rev. Med. Virol. 1, 145-154.
59. Tracy, S., Chapman, N.M. and Tu, Z. (1992) Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice. Arch. Virol. 122, 399-409.
60. Trousdale, M.D., Paque, R.E., Nealon, T. and Gauntt, C.J. (1979) Assessment of coxsackievirus B3 ts mutants for induction of myocarditis in a murine model. Infect. Immun. 23, 486-495.
61. Tu, Z., Chapman, N.M., Hufnagel, G., Tracy, S., Romero, J.R., Barry, W.H., Zhao, L., Currey, K. and Shapiro, B. (1995) The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5′ non-translated region. J. Virol. 69, 4607-4618.
62. Van Houten, N. and Huber, S. (1989) Role of cytotoxic T cells in experimental myocarditis. Springer Sem. Immunopathol. 11, 61-68.
63. Westrop, G.D., Wareham, K.A., Evans, D.M., Dunn, G., Minor, P.D., Magrath, D.I., Taffs, F., Marsden, S., Skinner, M.A., Schild, G.C. and Almond, J.W. (1989) Genetic basis of attenuation of the Sabin type 3 oral poliovirus vaccine. J. Virol. 63, 1338-1344.
64. Wimmer, E., Hellen, C.V.T. and Cao, X. (1993) Genetics of poliovirus. Ann. Rev. Genet. 27, 353-436.
65. Wolfgram, L.J. and Rose, N.R. (1989) Coxsackievirus infection as a trigger of cardiac autoimmunity. Immunol. Res. 8, 61-80.
66. Zhang, H.Y., Yousef, G.E., Cunningham, L., Blake, N.W., Ou Yang, X., Bayston, T.A., Kandolf, R. and Archard, L.C. (1993) Attenuation of a reactivated cardiovirulent coxsackievirus B3: the 5′ nontranslated region does not contain major attenuation determinants. J. Med. Virol. 41, 129-137.